We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India Considering New Regulatory Hurdles for Reformulated Drugs
India Considering New Regulatory Hurdles for Reformulated Drugs
India’s drug regulators are drafting new rules that would classify drugs with new formulations and delivery mechanics as “new drugs” — a move that would require drugmakers to conduct additional trials before selling the products.